New nerve block may ease pain after kidney transplant

NCT ID NCT07369323

Completed Symptom relief Sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a nerve block called an erector spinae plane (ESP) block can reduce pain and the need for strong painkillers after a kidney transplant. Forty adults having a kidney transplant were randomly assigned to receive either the ESP block or no block. All patients received standard pain medicine. The researchers measured pain scores and opioid use for 24 hours after surgery. The goal was to see if the block improves pain control and reduces side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bupivacaine (nerve block)
What this could lead to: If effective, this nerve block could become a standard way to manage pain after kidney transplant, reducing the need for opioids and their side effects.
What could go wrong: This is a small, single-center study with only 40 patients. The results may not apply to all transplant patients, and nerve blocks carry risks like infection or bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia end stage renal failure kidney failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KIDNEY FAILURE

Contacts and locations

Locations

Kartal Dr Lutfi Kırdar City Hospital

Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.